Xpar Vision had asserted its EP 0 643 297 B1 patent in Germany, France and Spain against the Tiama - MSG&SGCC I-care system.

During a recent meeting between the management of the parties, Xpar Vision and MSC&SGCC agreed to settle all disputes and stop all legal actions between the parties.

On the basis of the settlement, TIAMA - MSC&SGCC is now free to manufacture, use, promote and sell its I-care system worldwide without restrictions.

The settlement agreement has immediate effect.